Your browser doesn't support javascript.
loading
Effects of mean arterial pressure target on mottling and arterial lactate normalization in patients with septic shock: a post hoc analysis of the SEPSISPAM randomized trial.
Fage, Nicolas; Demiselle, Julien; Seegers, Valérie; Merdji, Hamid; Grelon, Fabien; Mégarbane, Bruno; Anguel, Nadia; Mira, Jean-Paul; Dequin, Pierre-François; Gergaud, Soizic; Weiss, Nicolas; Legay, François; Le Tulzo, Yves; Conrad, Marie; Coudroy, Remi; Gonzalez, Frédéric; Guitton, Christophe; Tamion, Fabienne; Tonnelier, Jean-Marie; Bedos, Jean Pierre; Van Der Linden, Thierry; Vieillard-Baron, Antoine; Mariotte, Eric; Pradel, Gaël; Lesieur, Olivier; Ricard, Jean-Damien; Hervé, Fabien; Du Cheyron, Damien; Guerin, Claude; Mercat, Alain; Teboul, Jean-Louis; Radermacher, Peter; Asfar, Pierre.
Afiliação
  • Fage N; Department of Medical Intensive Care, University Hospital of Angers, Angers, France.
  • Demiselle J; MITOVASC Laboratory UMR INSERM (French National Institute of Health and Medical Research), 1083 - CNRS 6015, University of Angers, Angers, France.
  • Seegers V; Department of Intensive Care (Service de Médecine Intensive - Réanimation), Nouvel Hôpital Civil, University Hospital of Strasbourg, Strasbourg, France.
  • Merdji H; INSERM (French National Institute of Health and Medical Research), UMR 1260, Regenerative Nanomedicine (RNM), FMTS (Fédération de Médecine Translationnelle de Strasbourg), University of Strasbourg, Strasbourg, France.
  • Grelon F; Service de Biométrie, Institut de Cancérologie de L'Ouest, Centre Paul Papin, Angers, France.
  • Mégarbane B; Department of Intensive Care (Service de Médecine Intensive - Réanimation), Nouvel Hôpital Civil, University Hospital of Strasbourg, Strasbourg, France.
  • Anguel N; INSERM (French National Institute of Health and Medical Research), UMR 1260, Regenerative Nanomedicine (RNM), FMTS (Fédération de Médecine Translationnelle de Strasbourg), University of Strasbourg, Strasbourg, France.
  • Mira JP; Medical and Surgical Intensive Care Unit, Le Mans Hospital, Le Mans, France.
  • Dequin PF; Department of Medical and Toxicological Critical Care, Lariboisière Hospital, Paris University, INSERM UMRS-1144, Paris, France.
  • Gergaud S; Department of Medical Intensive Care, Bicêtre University Hospital, AP-HP, Paris-Saclay University, Le Kremlin Bicêtre, France.
  • Weiss N; Department of Medical Intensive Care, Cochin University Hospital, Paris, France.
  • Legay F; Department of Medical Intensive Care, Tours University Hospital, Tours, France.
  • Le Tulzo Y; Department of Surgical Intensive Care, University Hospital of Angers, Angers, France.
  • Conrad M; Department of Medical Intensive Care, Georges Pompidou European Hospital, Assistance Publique - Hôpitaux de Paris, University of Paris, Paris, France.
  • Coudroy R; Medical and Surgical Intensive Care Unit, Saint Brieuc Hospital, Saint Brieuc, France.
  • Gonzalez F; Department of Infectious Diseases and Medical Intensive Care, Rennes University Hospital, Rennes, France.
  • Guitton C; Department of Medical Intensive Care, Nancy University Hospital, Nancy, France.
  • Tamion F; Department of Medical Intensive Care, Université de Poitiers, CHU Poitiers, Poitiers, France.
  • Tonnelier JM; Department of Medical and Surgical Intensive Care, Avicenne Teaching Hospital, Bobigny, France.
  • Bedos JP; Department of Medical Intensive Care, Nantes University Hospital, Nantes, France.
  • Van Der Linden T; Department of Medical Intensive Care, Rouen University Hospital, Rouen, France.
  • Vieillard-Baron A; Department of Medical Intensive Care, Brest University Hospital, Brest, France.
  • Mariotte E; Intensive Care Unit, Versailles Hospital, Le Chesnay, France.
  • Pradel G; Department of Intensive Care, Saint Philibert Hospital, Catholic University of Lille, Lille, France.
  • Lesieur O; Department of Medical Intensive Care, University Hospital of Ambroise Paré, Boulogne Billancourt, France.
  • Ricard JD; Inserm U1018, Center for Research in Epidemiology and Population Health (CESP), Faculty of Paris Saclay, Villejuif, France.
  • Hervé F; Department of Intensive Care, Saint Louis Hospital, Paris, France.
  • Du Cheyron D; Department of Intensive Care, Avignon Hospital, Avignon, France.
  • Guerin C; Department of Medical and Surgical Intensive Care, La Rochelle Saint Louis Hospital, La Rochelle, France.
  • Mercat A; Université de Paris, AP-HP, Hôpital Louis Mourier, DMU ESPRIT, Médecine Intensive Réanimation, Colombes, France.
  • Teboul JL; Department of Medical and Surgical Intensive Care, Quimper Hospital, Quimper, France.
  • Radermacher P; Department of Medical Intensive Care, Caen University Hospital, Caen, France.
  • Asfar P; Department of Medical Intensive Care, Edouard Herriot Hospital, Lyon, France.
Ann Intensive Care ; 12(1): 78, 2022 Aug 19.
Article em En | MEDLINE | ID: mdl-35984574
BACKGROUND: In patients with septic shock, the impact of the mean arterial pressure (MAP) target on the course of mottling remains uncertain. In this post hoc analysis of the SEPSISPAM trial, we investigated whether a low-MAP (65 to 70 mmHg) or a high-MAP target (80 to 85 mmHg) would affect the course of mottling and arterial lactate in patients with septic shock. METHODS: The presence of mottling was assessed every 2 h from 2 h after inclusion to catecholamine weaning. We compared mottling and lactate time course between the two MAP target groups. We evaluated the patient's outcome according to the presence or absence of mottling. RESULTS: We included 747 patients, 374 were assigned to the low-MAP group and 373 to the high-MAP group. There was no difference in mottling and lactate evolution during the first 24 h between the two MAP groups. After adjustment for MAP and confounding factors, the presence of mottling ≥ 6 h during the first 24 h was associated with a significantly higher risk of death at day 28 and 90. Patients without mottling or with mottling < 6 h and lactate ≥ 2 mmol/L have a higher probability of survival than those with mottling ≥ 6 h and lactate < 2 mmol/L. CONCLUSION: Compared with low MAP target, higher MAP target did not alter mottling and lactate course. Mottling lasting for more than 6 h was associated with higher mortality. Compared to arterial lactate, mottling duration appears to be a better marker of mortality.
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Clinical_trials Idioma: En Revista: Ann Intensive Care Ano de publicação: 2022 Tipo de documento: Article País de afiliação: França País de publicação: Alemanha

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Clinical_trials Idioma: En Revista: Ann Intensive Care Ano de publicação: 2022 Tipo de documento: Article País de afiliação: França País de publicação: Alemanha